GPGrossPatternRESEARCH SYSTEM
SEC CHECK OPERATIONAL
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

MRBK · Sep 30, 2025

Meridian Corp. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration

State dimensions

Filing0001750735-25-000077Bank
Sequential deposit growth30thOwn-history percentile · N=20
Evidence method

Sequential · gp.financial.deposits

0.98% · CORE · VALID

Net-income growth75thOwn-history percentile · N=20
Evidence method

Yoy · gp.fundamentals.net_income

40.40% · CORE · VALID

Interest-income growth10thOwn-history percentile · N=20
Evidence method

Yoy · gp.financial.interest_income

6.92% · CORE · VALID

Cash and equivalents55thOwn-history percentile · N=20
Evidence method

Level · gp.fundamentals.cash

$40.0M · CORE · VALID

Sequential loan growth60thOwn-history percentile · N=20
Evidence method

Sequential · gp.financial.loans

2.57% · CORE · VALID

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History31 statesSelf-history eligible
Period transition

What moved in the state?

Deposit Growth Increased
Previous
-0.86%
Current
0.98%
Delta
1.85%
Earnings Growth Decreased
Previous
68.13%
Current
40.40%
Delta
-27.73%
Interest Income Growth Decreased
Previous
7.14%
Current
6.92%
Delta
-0.22%
Liquidity Decreased
Previous
$50.2M
Current
$40.0M
Delta
-$10.2M
Loan Growth Increased
Previous
1.78%
Current
2.57%
Delta
0.79%
Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Not enough compatible prior states for a transparent self-history match.
Research Graph

Related governed research

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.